salvinorin a has been researched along with Staphylococcal Pneumonia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, D; Gao, ZQ; Liu, G; Liu, L; Pang, QF; Shan, JC; Su, Y; Wu, YX; Yuan, JN; Zeng, S; Zhu, T | 1 |
1 other study(ies) available for salvinorin a and Staphylococcal Pneumonia
| Article | Year |
|---|---|
Salvinorin A protects against methicillin resistant staphylococcus aureus-induced acute lung injury via Nrf2 pathway.
Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents; Cytokines; Disease Models, Animal; Diterpenes, Clerodane; Inflammation Mediators; Lung; Macrophages; Male; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred C57BL; Mice, Knockout; Neutrophil Infiltration; NF-E2-Related Factor 2; Oxidative Stress; Pneumonia, Staphylococcal; RAW 264.7 Cells; Signal Transduction | 2021 |